Immune dendritic cells in human dermis

European Journal of Dermatology

Volumn 6, Issue 5, 1996, Pages 327-331

  Meunier, Laurent ^a  

^a UNIV MONTPELLIER   (France)

Author keywords

Antigen presenting cell; Dendritic cell; Dermis; Langerhans cell

Indexed keywords

ANTIGEN PRESENTATION; DENDRITIC CELL; DERMIS; HUMAN; HUMAN CELL; HUMAN TISSUE; LANGERHANS CELL; REVIEW;

EID: 0029947734     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (114)

1. Steinman RM. The dendritic cell system and its role in immunogenicity. Ann Rev Immunol 1991; 9: 271.
2. Thomas R, Davis LS, Lipsky PE. Isolation and characterization of human peripheral blood dendritic cells. J Immunol 1993; 150: 821-34.
3. Pavli P, Hume DA, Van de Pol E, Doe WF. Dendritic cells, the major antigen-presenting cells of the human colonic lamina propria. Immunology 1993; 78: 132-41.
4. Spencer SC, Fabre JW. Characterization of the tissue macrophage and the interstitial dendritic cell as distinct leukocytes normally reside in the connective tissue of the rat heart. J Exp Med 1990; 171: 1841-9.
5. Nicod LP, Lipscomb MF, Weissler JC, Toews GB. Mononuclear cells from human lung parenchyma support antigen-induced T lymphocyte proliferation. J Leuk Biol 1989; 45: 336-44
6. Freudenthal PS, Steinman RM. The distinct surface of human blood dendritic cells, as observed after an improved isolation method. Proc Natl Acad Sci USA 1990; 87: 7698.
7. Stingl G. Dendritic cells of the skin. Dermatologic Clinics 1990; 8: 673-9.
8. Symington FW, Brady W, Linsley PS. Expression and function of B7 on human epidermal Langerhans cells. J Immunol 1993; 150: 1286-95.
9. + T lymphocytes by human blood dendritic cells in vitro. J Clin Invest 1992; 90: 229-37.
10. Caux C, Vanbervliet B, Massacrier C, Azuma M, Okumura K, Lanier LL, Banchereau J. B70/B7-2 is identical to CD86 and is the major functional ligand for CD28 expressed on human dendritic cells. J Exp Med 1994; 180: 1841-7.
11. Yokozeki H, Katayama I, Ohki O, Matsunaga T, Watanabe K, Satoh T, Azuma M, Okumura K, Nishioka K. Functional CD86 (B7-2/B70) on cultured human Langerhans cells. J Invest Dermatol 1996; 106: 147-53.
12. Osada A, Nakashima H, Furue M, Tamaki K. Up-regulation of CD44 expression by tumor necrosis factor-alpha is neutralized by interleukin-10 in Langerhans cells. J Invest Dermatol 1995; 105: 124-7.
13. Aiba S, Nakagawa S, Ozawa H, Miyake K, Yagita H, Tagami H. Up-regulation of α4 integrin on activated Langerhans cells: analysis of adhesion molecules on Langerhans cells relating to their migration from skin to draining lymph nodes. J Invest Dermatol 1993; 100: 143-7.
14. Stingl G, Bergstresser PR. Dendritic cells - a major story unfolds, Immunology Today 1995; 16: 330-3.
15. De Fougerolles AR, Qin X, Springer TA. Characterization of the function of intercellular adhesion molecule (ICAM)-3 and comparison with ICAM-1 and ICAM-2 in immune responses. J Exp Med 1994; 179: 619-29.
16. Hart DN, Prickett TC. Intercellular adhesion molecule-2 (ICAM-2) expression on human dendritic cells. Cell Immunol 1993; 148: 447-54.
17. + cells. Br J Dermatol 1995; 133: 823-9.
18. Starling, GC, McLellan AD, Egner W, Sorg RV, Fawcett J, Simmons DL, Hart DNJ. Intercellular adhesion molecule-3 is the predominant co-stimulatory ligand for leukocyte function antigen-1 on human blood dendritic cells. Eur J Immunol 1995; 25: 2528-32.
19. Teunissen MBM, Koomen CW, Bos JD. Intercellular adhesion molecule-3 (CD50) on human epidermal Langerhans cells participates in T cell activation J Invest Dermatol 1995; 104: 995-8.
20. Grabbe S, Beissert S, Schwarz T, Granstein RD. Dendritic cells as initiators of tumor immune responses: a possible strategy for tumor immunotherapy? Immunology Today 1995; 16: 117-21.
21. Katz SI, Tamaki K, Sachs DH. Epidermal Langerhans cells are derived from cells originating in bone marrow. Nature 1979; 282: 324.
22. Stingl G, Katz SI, Green I, Shevach EM. The functional role of Langerhans cells. J Invest Dermatol 1980; 74: 315-8.
23. + epidermal cell. J Invest Dermatol 1985; 85: 546-51.
24. Schuler G, Steinmann RG. Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro. J Exp Med 1985; 161: 526-46.
25. Romani N, Koide S, Growley M, Witmer-Pack M, Livingstone AM, Pathman CG, Inaba K, Steinman RM. Presentation of exogenous protein antigens by dendritic cells to T cell clones. Intact protein is presented best by immature, epidermal Langerhans cells. J Exp Med 1989; 169: 1169-78.
26. Romani N, Lenz A, Glassel H, Stossel H, Stanzl U, Majdic O, Fritsch P, Schuler G. Cultured human Langerhans cells resemble lymphoid dentritic cells in phenotype and function. J Invest Dermatol 1989; 93: 600-9.
27. + cells are capable of initiating delayed type hypersensitivity responses. J Invest Dermatol 1990; 94: 267-72.
28. Murphy GF, Bhan AK, Harrist TJ, Mihm MC. In situ identification of T6-positive cells in normal human dermis by immunoelectron microscopy, Br J Dermatol 1983; 108: 423-31.
29. Sontheimer RD, Matsubara T, Seelig LL. A macrophage phenotype for a constitutive, class II antigen-expressing, human dermal perivascular dendritic cell. J Invest Dermatol 1989; 93: 154-9.
30. Weber-Matthiesen K, Sterry W. Organization of the monocyte/macrophage system of normal human skin. J Invest Dermatol 1990; 95: 83-9.
31. Nickoloff BJ. Dermal immune system. Florida: CRC Press, Boca Raton, 1993.
32. Rowden G, Phillips TM, Lewis MG. la antigens on indeterminate cells of the epidermis: immunoelectronmicroscopic studies of surface antigens, Br J Dermatol 1979; 100: 531.
33. Kuwabara H, Uda H. Saito K, Maruyama T, Tanaka S. Dendritic cells in the murine dermis in delayed-type contact hypersensitivity. Acta Pathol Jpn 1991; 41: 106-12.
34. Sontheimer RD. Perivascular dendritic macrophages as immunobiological constituents of the human dermal microvascular unit. J Invest Dermatol 1989; 93: 96S-101S.
35. + perivascular dendritic cells. J Invest Dermatol 1991; 96: 333-40.
36. Nickoloff BJ, Griffiths CEM. Factor XIIIa expressing dermal dendrocytes in Kaposi's sarcomas. Science 1989; 243: 1736-7.
37. Huang YQ, Friedman-Kien AE, Li JJ, Nickoloff BJ. Cultured Kaposi's sarcoma cell lines express factor XIIIa, CD14, and VCAM-1, but not factor VIII or ELAM-1. Arch Dermatol 1993; 129: 1291-6.
38. (+) dentritic cells in human burn wounds. J Surg Res 1995; 59: 378-86.
39. Cerio R, Spaull J, Oliver GF, Jones EW. A study of factor XIIIa and MAC 387 immunolabeling in normal and pathological skin. Am J Dermatopathol 1990; 12: 221-33.
40. Cerio R Griffiths CEM, Cooper KD, Nickoloff BJ, Headington JT. Characterization of factor XIIIa positive dermal dendritic cells in normal and inflamed skin. Br J Dermatol 1989; 121: 421-31.
41. + dermal perivascular dentritic cells. Lab Invest 1991; 65: 732-41.
42. Nickoloff BJ. The human progenitor cell antigen (CD34) is localized on endothelial cells, dermal dendritic cells, and perifollicular cells in formalin-fixed normal skin, and on proliferating endothelial cells and stromal spindle-shaped cells in Kaposi's sarcoma. Arch Dermatol 1991; 127: 523-9.
43. Sueki H, Whitaker D, Buschsbaum M. Murphy GF. Novel interaction between dermal dendrocytes and mast cells in human skin. Implications for homeostasis and matrix repair. Lab Invest 1993; 69: 160-72.
44. Sueki H, Telegan B, Murphy GF. Computer-assisted three-dimensional reconstruction of human dermal dendrocytes. J Invest Dermatol 1995; 105: 704-8.
45. (+) cells in developing human skin. Anatomy & Embryol 1996; 193: 35-41.
46. Braverman IM, Sibley J, Keh-Yen A. A study of the veil cells around normal, diabetic, and aged cutaneous microvessels. J Invest Dermatol 1986; 86: 57-62.
47. Hughes CC, Savage COS, Prober JS. Endothelial cells augment T cell interleukin-2 production by a contact-dependent mechanism involving CD2/LFA-3 interaction. J Exp Med 1990; 171: 1453-67.
48. Headington JT Cerio R. Dendritic cells and the dermis; 1990. Am J Dermatopathol 1990;12: 217-20
49. Narvaez D Kanitakis J, Cloudy A. Dendritic cells of human dermis. Eur J Dermatol 1995; 5: 69-76.
50. Furue M, Nindl M, Kawabe K, Nakamura K, Ishibashi Y, Sagawa K. Epitopes for CD1a, CD1b, and CD1c antigens are differentially mapped on Langerhans cells, dermal dendritic cells, keratinocvtes, and basement membrane zone in human skin. J Am Acad Dermatol 1992; 27: 419-26.
51. + cells in human dermal cell suspensions. Identification of a small subset responsible for potent dermal antigen-presenting cell activity with features analogous to Langerhans cells. J Immunol 1993; 151: 4067-80.
52. Nestle FO, Zheng X, Thompson CB, Turka LA, Nickoloff BJ. Characterization of dermal dendritic cells obtained from normal human skin reveals phenotypic and functionally distinctive subsets. J Immunol 1993; 151: 6535-45.
53. Lenz A, Heine M, Schuler G, Romani N. Human and murine dermis contain dendritic cells. J Clin Invest 1993; 92: 2587-96.
54. + Langerhans cell-like interstitial dendritic antigen-presenting cells in murine dermis from dermal macrophages. J Invest Dermatol 1994; 103: 678-83.
55. Knowles RW, Bodmer WF. A monoclonal antibody recognizing a human thymus leukemia-like antigen associated with β2-microglobulin. Eur J Immunol 1982; 12: 676-81.
56. Van de Rinjn M, Lerch PG, Bronstein BR, Knowles RW, Bhan AK, Terhorst C. Human cutaneous dendritic cells express two glycoproteins T6 and M241 which are biochemically identical to those found on cortical thymocytes. Hum Immunol 1984; 9: 201-10.
57. Cattoretti GE, Berti E, Parravicini N, Polli N, Buscaglia M. CD1 positive dendritic cells: ontogeny and tissue distribution in humans. Tissue Antigens 1989; 33: 67 (abstr.).
58. Murphy GF, Bronstein BR, Knowles RW, Bhan AK. Ultrastructural documentation of M241 glycoprotein on dendritic and endothelial cells in normal human skin. Lab Invest 1985; 52: 264-9.
59. - cytolytic T lymphocytes. Nature 1996; 341: 447-50.
60. Lonati A, Mommaas MA, Pasolini G, Lavazza A. Rowden G, De Panfilis G. Macrophages, but not Langerhans cell-like cells of dendritic lineage, express the CD36 molecule in normal human dermis: relevance to downregulatory cutaneous immune responses? J Invest Dermatol 1996; 106: 96-101.
61. + cells. Br J Dermatol 1994; 131: 15-22.
62. Hirschberg HS, Bergh OJ, Thorsby E. Antigen-presenting properties of human vascular endothelial cells. J Exp Med 1980; 152: 249S-55S.
63. + cells that enhance epidermal alloantigen presentation. J Immunol 1985; 134: 129-37.
64. De Panfilis G, Soligo D, Manara GC, Ferrari C, Torresani C. Adhesion molecules on the plasma membrane of epidermal cells. I. Human resting Langerhans cells express members of the adherence-promoting CD11/CD18 Family, H-Mac-1 (CD11b-CD18) and gp 150,95 (CD11c/CD18). J Invest Dermatol 1989; 93: 60-9.
65. Hart DN, McKenzie JL. Isolation and characterization of human tonsil dendritic cells. J Exp Med 1988; 168: 157.
66. Stacker SA, Springer TA. Leukocyte integrin P150,95 (CD11c/CD18) functions as an adhesion molecule binding to a counter-receptor on stimulated endothelium. J Immunol 1991; 146: 648-55.
67. Meunier L, Bohjanen K, Voorhees JJ, Cooper KD. Retinoic acid upregulates human Langerhans cell antigen presentation and surface expression of HLA-DR and CD11c, a β2 integrin critically involved in T cell activation. J Invest Dermatol 1994; 103: 775-9.
68. Caux C, Massacrier C, Vanbervliet B, Dubois B, Vankooten C, Durand I, Banchereau J. Activation of human dendritic cells through CD40 cross-linking. J Exp Med 1994; 180: 1263-72.
69. Teunissen MBM, Wormmeester J, Krieg SR, Peters PJ, Vogels IMC, Kapsenberg ML, Bos JD. Human epidermal Langerhans cells undergo profound morphologic and phenotypical changes during in vitro culture. J Invest Dermatol 1990; 94: 166-73.
70. Nakamura K, Williams IR, Kupper TS. Keratinocyte-derived monocyte chemoattractant protein 1 (MCP-1): analysis in a transgenic model demonstrates MCP-1 can recruit dendritic and Langerhans cells to skin. J Invest Dermatol 1995; 105: 635-43.
71. Ansel JC, Kaynard AH, Armstrong CA, Olerud J, Bunnett N, Payan D. Skin-nervous system interactions. J Invest Dermatol 1996; 106: 198-204.
72. Streilen JW. Antigen-presenting cells in the induction of contact hypersensitivity in mice: evidence that Langerhans cells are sufficient but not required. J Invest Dermatol 1989; 933: 448.
73. Dranoff G, Jaffe E, Lazenby A, Gloumbek P, Levitsky H, Brose K, Jackson V, Hamada H, Pardoll D, Mulligan RC. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc Natl Acad Sci USA 1993; 90: 3539-47.
74. Osterhoff B, Rappersberger K, Wang B, Koszik F. Ochiai K, Kinet J, Stingl G. Immunomorphologic characterization of FcεRI-bearing cells within the human dermis. J Invest Dermatol 1994; 102: 315-20.
75. Bata-Csorgo ZS, Hammerberg C, Voorhees JJ, Cooper KD. Intralesional T-lymphocyte activation as a mediator of psoriatic epidermal hyperplasia. J Invest Dermatol 1995; 105: 89S-94S.
76. Lappin MB, Kimber I, Norval M. The role of dendritic cells in cutaneous immunity. Arch Dermatol Res 1996; 288: 109-21.
77. Nickoloff BJ, Griffiths CEM. Lymphocyte trafficking in psoriasis: a new perspective emphasizing the dermal dendrocyte with active dermal recruitment mediated by endothelial cells followed by intra-epidermal T cell activation. J Invest Dermatol 1990; 95: 35S-7S.
78. Bata-Csorgo ZS, Hammerberg C, Voorhees JJ, Cooper KD. Flow cytometric identification of proliferative subpopulations within normal human epidermis and the localization of the primary hyperproliferative population in psoriasis. J Exp Med 1993; 178: 1271-81.
79. Bata-Csorgo Z, Hammerberg C, Voorhees JJ, Cooper KD. Kinetics and regulation of human keratinocytes stem cell growth in short-term primary ex vivo culture-cooperative growth factor from psoriatic lesional T lymphocytes stimulate proliferation among psoriatic uninvolved, but not normal, stem keratinocytes. J Clin Invest 1995; 95: 317-27.
80. Nestle FO, Turka LA, Nickoloff BJ. Characterization of dermal dendritic cells in psoriasis. J Clin Invest 1994; 94: 202-4.
81. Mitra RS, Judge TA, Nestle FO, Turka LA, Nickoloff BJ. Psoriatic skin-derived dendritic cell function is inhibited by exogenous IL-10 differential modulation of B7-1 (CD80) and B7-2 (CD86) expression. J Immunol 1995; 154: 2668-77.
82. + antigen-presenting cells and activated macrophages. J Am Acad Dermatol 1988; 19: 633-41.
83. Cooper KD, Duraiswamy N, Hammerberg C, Allen E, Kimbrough-Green C, Dillon W, Thomas D. Neutrophils, differentiated macrophages, and monocyte/macrophage antigen presenting cells infiltrate murine epidermis after UV injury. J Invest Dermatol 1993; 101: 155-63.
84. + Langerhans-like dendritic antigen-presenting cells are concomitantly depleted. J Invest Dermatol 1995; 105: 782-8.
85. Cooper KD. Role of antigen-presenting cell/T lymphocyte interactions in benign and malignant skin diseases. J Clin Invest 1993: 68-73.
86. Cooper KD. Skin-infiltrating lymphocytes in normal and disorders skin: activation signals and functional roles in psoriasis and mycosis fungoides-type cutaneous T cell lymphoma. J Dermatol 1992; 19: 731-7.
87. Baadsgaard O, Gupta AK, Taylor RS, Ellis CN, Voorhees JJ, Cooper KD. Psoriatic epidermal cells demonstrate increased numbers and function of non-Langerhans antigen-presenting cells. J Invest Dermatol 1989; 92: 190-5.
88. + melanophages appear in human epidermis after ultraviolet radiation. J Invest Dermatol 1986; 86: 363-70.
89. Shibaki A, Ohkawara A, Cooper KD. Differential extracellular signaling via Fc gamma R and FMLP in functionally distinct antigen-presenting cell subsets: ultraviolet-induced epidermal macrophages versus Langerhans cells. J Invest Dermatol 1995; 105: 383-7.
90. + macrophages that infiltrate human epidermis after in vivo ultraviolet exposure potently produce IL-10 and represent the major secretory source of epidermal IL-10 protein. J Immunol 1994; 13: 5256-64.
91. Stevens SR, Shibaki A, Meunier L, Cooper KD. Suppressor T cell-activating macrophages in UV-irradiated human skin induce a novel, TGFβ-dependent, form of T cell activation characterized by deficient IL-2Rα expression. J Immunol 1995; 155: 5601-7.
92. + antigen-presenting cells in human epidermis. J Invest Dermatol 1987; 89: 113-8.
93. + suppressor/cytotoxic lymphocytes. J Immunol 1988; 140: 1738-44.
94. Baadsgaard O, Lisby S, Wantzin GL, Wulf HC, Cooper KD. Rapid recovery of Langerhans cell alloreactivity, without induction of autoreactivity, after in vivo ultraviolet A, but not ultraviolet B exposure of human skin. J Immunol 1989; 142: 4213-8.
95. + suppressor-inducer T cells. J Immunol 1990; 145: 2854-61.
96. Inaba K, Inaba M, Degachi M, Hagi K, Yasumizu R, Ikehara S, Muramatsa S, Steinman R. Granulocytes, macrophages and dendritic cells arise from a common major histocompatibility complex class-negative progenitor in mouse bone marrow. Proc Natl Acad Sci USA 1993; 90: 3038.
97. Murphy GF, Messadi D, Fonferko E, Hancock WW. Phenotypic transformation of macrophages to Langerhans cells in the skin. Am J Dermatopathol 1986; 123: 401-6.
98. Cooper KD, Kang K, Kubin M, Trinchieri G, Rook AH. Opposing cytokine production by normal Langerhans cells (IL-12) and UV-induced macrophages (IL-10). J Invest Dermatol 1994; 103: 434 (abstr.).
99. Berg DJ, Leach MW, Kuhn R, Rajewsky K, Muller W, Davidson NJ, Rennick D. Interleukin-10 but not interleukin-4 is a natural suppressant of cutaneous inflammatory responses. J Exp Med 1995; 182: 99-108.
100. Li L, Elliot JF, Mosmann TR. IL-10 inhibits cytokine production, vascular leakage, and swelling during T helper 1 cell-induced delayed-type hypersensitivity. J Immunol 1994; 153: 3967.
101. Del Prete G, De Carli M, Almerigogna F, Giudizi MG, Biagiotti R, Romagnani S. Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J Immunol 1993; 150: 353-60.
102. Enk AH, Angeloni VL, Udey MC, Katz SI. Inhibition of Langerhans cell antigen-presenting function by IL-10. A role for IL-10 in induction of tolerance. J Immunol 1993; 151: 2390-8.
103. Fiorentino DF, Zlotnik A, Viera P, Mosmann TR, Howard M, Moore KW, O'Garra A. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol 1991; 146: 3444-51.
104. Heufler CH, Toper G, Wysocka M, Koch F, Stanzl U, Janke K, Koll D, Schuler G. Dendritic cells are a source of interleukin-12. J Invest Dermatol 1994; 103: 418 (abstr.).
105. + T cells. J Immunol 1995; 154: 5071-9.
106. Trinchieri G, Scott P. The role of interleukin-12 in the immune response, disease and therapy. Immunology Today 1994; 15: 460-3.
107. Gonzalez-Ramos A, Cooper KD, Hammerberg C. Identification of a human dermal macrophage population responsible for constitutive restraint of primary dermal fibroblast proliferation. J Invest Dermatol 1996; 106: 305-11.
108. Girolomoni G, Ricciardi-Gastagnoli P. Immortal mouse dendritic cell lines: new models to investigate the immunobiology of dendritic cells. Eur J Dermatol 1995; 5: 12-5.
109. Inaba K, Steinman RM, Witmer Pack M, Aya H, Inaba M, Sudo T, Wolpe S, Schuler G. Identification of proliferating dendritic cell precursors in mouse blood. J Exp Med 1992; 175: 1157-67.
110. Inaba K, Inaba M, Romani N, Aya H, Deguchi M, Ikehara S, Muramatsu S, Steinman RM. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocytes/macrophage colony-stimulating factor. J Exp Med 1992; 176: 1693-702.
111. Caux C, Dezutter-Dambuyant C, Schmitt D, Blanchereau J. GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells. Nature 1992; 360: 258-61.
112. Romani N, Gruner S, Brang D, Kampgen E, Lenz A, Trockenbacher B, Konwalinka G, Fritsch PO, Steinman RM, Schuler G. Proliferating dendritic cell progenitors in human blood. J Exp Med 1994; 180: 83-93.
113. Paglia P, Girolomoni G, Robbiati F, Granucci F, Ricciardi-Castagnoli P. Immortalized dendritic cell line fully competent in antigen presentation initiates primary T cell responses in vivo. J Exp Med 1993; 178: 1893-901.
114. Bour H, Demidem A, Garrigue J, Krasteva M, Schmitt D, Cloudy A, Nicolas JF. In vitro T cell response to staphylococcal enterotoxin B superantigen in chronic plaque type psoriasis. Acta Dermatol Venereol 1995; 75: 218-21.